• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Amino acid changes in HA and determinants of pathogenicity associated with influenza virus A H1N1pdm09 during the winter seasons 2015-2016 and 2016-20

tetano

Editor, Senior Moderator
Virus Res. 2019 Aug 21:197731. doi: 10.1016/j.virusres.2019.197731. [Epub ahead of print]
[h=1]Amino acid changes in HA and determinants of pathogenicity associated with influenza virus A H1N1pdm09 during the winter seasons 2015-2016 and 2016-2017 in Mexico.[/h] Joel Armando VP[SUP]1[/SUP], Daniela RZ[SUP]2[/SUP], Emmanuel V?[SUP]3[/SUP], Horacio GL[SUP]3[/SUP], Norma Ang?lica TN[SUP]3[/SUP], Fernando C[SUP]3[/SUP], Crist?bal GP[SUP]3[/SUP], Luis SJ[SUP]3[/SUP], Manuel CL[SUP]3[/SUP], Rodolfo Norberto JJ[SUP]2[/SUP], Jos? Luis SH[SUP]2[/SUP], Brenda Berenice PM[SUP]2[/SUP], Rogelio PP[SUP]3[/SUP].
[h=3]Author information[/h] 1 Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas, Mexico City, Mexico. Electronic address: joevazpe@gmail.com. 2 Hospital Infantil de M?xico Federico G?mez, Mexico City, Mexico. 3 Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas, Mexico City, Mexico.

[h=3]Abstract[/h] Biennial H1N1pdm09 influenza A virus (IAV) epidemics have been associated with major severity of respiratory disease in Mexico. Atypically and in contrast with what happened in USA, Canada and Europe during 2017, an increase of infections due to the H1N1pdm09 pandemic virus instead of H3N2 was observed. In order to determine the viral contribution to severe acute respiratory disease, we characterized the pathogenicity determinants of IAV in Mexico during the 2015-2016 and 2016-2017 seasons. The RNA segments of 20 IAV samples were sequenced by NGS platform and phylogenetic analysis was conducted. The analysis of the hemagglutinin (HA) sequences established that all virus samples, except one, belong to clade (6B.1). The IAVs presented the substitution S162 N, which introduces a new glycosylation site in the hemagglutinin. We also found the D222 G substitution, which has been associated with a higher tropism towards the lower respiratory tract, and a non-reported insertion of one Ile in NS1 (Ile113). The IAVs from 2016-2017 in Mexico belong to the new clade 6B.1. The new glycosylation site in HA (S162 N) is a major change that may affect the efficacy of the current vaccine. We detected in several patients pathogenicity determinants associated with the severity of the respiratory disease.
Copyright ? 2019. Published by Elsevier B.V.


[h=4]KEYWORDS:[/h] AH1N1pdm09; Influenza virus; molecular determinants; pathogenicity

PMID: 31445105 DOI: 10.1016/j.virusres.2019.197731
 
Back
Top